The Study of Biochemical Factors of Calcification of Stable and Unstable Plaques in the Coronary Arteries of Man

Objective. The aim of the study was to study biochemical factors of calcification in stable and unstable plaques of coronary arteries and in the blood of patients with severe coronary atherosclerosis, to find associations of biochemical factors of calcification with the development of unstable atherosclerotic plaque.
Materials and Methods. The study included 25 men aged 60,4±6,8 years who received coronary bypass surgery. In the course of the operation intraoperative indications in men were from coronary endarteriectomy (s) artery (a – d) and histological and biochemical analyses of the samples of the intima / media. Out of 85 fragments of intima / media of coronary arteries, 15 fragments of unchanged intima / media, 39 fragments of stable atheromatous plaque and 31 fragments of unstable plaque were determined. In homogenates of samples of intima / media (after measurement of protein by the method of Lowry) and in blood by ELISA were determined by biochemical factors of calcification: osteoprotegerin, osteocalcin, an osteopontin, osteonectin, as well as inflammatory factors (cytokines, chemokines).
Results. A significant direct correlation (Spearman coefficient =0.607, p<0.01) between the stages of atherosclerotic focus development to unstable plaque and the degree of calcification of atherosclerotic focus development samples was found. There was an increased content of osteocalcin in stable and unstable plaques by 3.3 times in comparison with the unchanged tissue of intima / media of coronary arteries, as well as in samples with small and dust-like, with coarse-grained calcifications in comparison with samples without calcifications by 2.8 and 2.1 times, respectively. According to multivariate logistic regression analysis, the relative risk of unstable atherosclerotic plaque in the coronary artery is associated with a reduced content of osteocalcin (OR=0.988, 95 % CI 0.978–0.999, p=0.028). Also, the relative risk of calcifications in the atherosclerotic plaque in the coronary artery is associated with an increased content of osteocalcin (OR=1,008, 95 % CI 1,001–1,015, p=0,035). In men with severe coronary atherosclerosis, a significant inverse correlation was found (Spearman coefficient –0.386, p=0.022) between the content of osteoprotegerin in the vascular wall and in the blood.

1. Borissoff JI, Joosen IA, Versteylen MO, Spronk HM, ten Cate H, Hofstra L. Accelerated In Vivo Thrombin Formation Independently Predicts the Presence and Severity of CT Angiographic Coronary Atherosclerosis. JACC: Cardiovascular Imaging. 2012;5(12):1201–10. DOI: 10.1016/j.jcmg.2012.01.023

2. Alexopoulos N, Raggi P. Calcification in atherosclerosis. Nature Reviews Cardiology. 2009;6(11):681–8. DOI: 10.1038/nrcardio.2009.165

3. Shaw LJ, Giambrone AE, Blaha MJ, Knapper JT, Berman DS, Bellam N et al. Long-Term Prognosis After Coronary Artery Calcification Testing in Asymptomatic Patients: A Cohort Study. Annals of Internal Medicine. 2015;163(1):14–21. DOI: 10.7326/M14-0612

4. Stone GW, Maehara A, Lansky AJ, de Bruyne B, Cristea E, Mintz GS et al. A Prospective Natural-History Study of Coronary Atherosclerosis. New England Journal of Medicine. 2011;364(3):226–35. DOI: 10.1056/NEJMoa1002358

5. Hofmann Bowman MA, McNally EM. Genetic Pathways of Vascular Calcification. Trends in Cardiovascular Medicine. 2012;22(4):93–8. DOI: 10.1016/j.tcm.2012.07.002

6. O’Donnell CJ, Kavousi M, Smith AV, Kardia SLR, Feitosa MF, Hwang S-J et al. Genome-Wide Association Study for Coronary Artery Calcification With Follow-Up in Myocardial Infarction. Circulation. 2011;124(25):2855–64. DOI: 10.1161/CIRCULATIONAHA.110.974899

7. Zhan Y, Zhang Y, Hou J, Lin G, Yu B. Relation Between Superficial Calcifications and Plaque Rupture: An Optical Coherence Tomography Study. Canadian Journal of Cardiology. 2017;33(8):991–7. DOI: 10.1016/j.cjca.2017.05.003

8. Oliveira-Santos M de, Castelo-Branco M, Silva R, Gomes A, Chichorro N, Abrunhosa A et al. Atherosclerotic plaque metabolism in high cardiovascular risk subjects – A subclinical atherosclerosis imaging study with 18 F-NaF PET-CT. Atherosclerosis. 2017;260:41–6. DOI: 10.1016/j.atherosclerosis.2017.03.014

9. Kashtalap V.V., Hryachkova O.N., Barbarash O.L. Clinical Significance of Coronary Calcification for the Assessment of Cardiovascular Risk. Atherosclerosis and Dyslipidemias. 2016;1(22):5–14. In Russian

10. Davaine J-M, Quillard T, Chatelais M, Guilbaud F, Brion R, Guyomarch B et al. Bone Like Arterial Calcification in Femoral Atherosclerotic Lesions: Prevalence and Role of Osteoprotegerin and Pericytes. European Journal of Vascular and Endovascular Surgery. 2016;51(2):259–67. DOI: 10.1016/j.ejvs.2015.10.004

11. Inaba M, Ueda M. Vascular Calcification Pathological Mechanism and Clinical Application The significance of arterial calcification in unstable plaques. Clinical Calcium. 2015;25(5):679–86. DOI: CliCa1505679686

12. Zhang H, Wang L, Si D, Wang C, Yang J, Jiang P et al. Correlation between osteocalcin-positive endothelial progenitor cells and spotty calcification in patients with coronary artery disease. Clinical and Experimental Pharmacology and Physiology. 2015;42(7):734–9. DOI: 10.1111/1440-1681.12366

13. Wookey PJ, Zulli A, Hare DL. The elevated expression of calcitonin receptor by cells recruited into the endothelial layer and neo-intima of atherosclerotic plaque. Histochemistry and Cell Biology. 2009;132(2):181–9. DOI: 10.1007/s00418-009-0600-6

14. Qiao J-H, Mishra V, Fishbein MC, Sinha SK, Rajavashisth TB. Multinucleated giant cells in atherosclerotic plaques of human carotid arteries: Identification of osteoclast-like cells and their specific proteins in artery wall. Experimental and Molecular Pathology. 2015;99(3):654– 62. DOI: 10.1016/j.yexmp.2015.11.010

15. Higgins CL, Isbilir S, Basto P, Chen IY, Vaduganathan M, Vaduganathan P et al. Distribution of Alkaline Phosphatase, Osteopontin, RANK Ligand and Osteoprotegerin in Calcified Human Carotid Atheroma. The Protein Journal. 2015;34(5):315–28. DOI: 10.1007/s10930-015-9620-3

16. Foresta C, Strapazzon G, De Toni L, Fabris F, Grego F, Gerosa G et al. Platelets express and release osteocalcin and co-localize in human calcified atherosclerotic plaques. Journal of Thrombosis and Haemostasis. 2013;11(2):357–65. DOI: 10.1111/jth.12088

17. Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR et al. Coronary Calcium as a Predictor of Coronary Events in Four Racial or Ethnic Groups. New England Journal of Medicine. 2008;358(13):1336–45. DOI: 10.1056/NEJMoa072100

18. Kiechl S, Schett G, Wenning G, Redlich K, Oberhollenzer M, Mayr A et al. Osteoprotegerin Is a Risk Factor for Progressive Atherosclerosis and Cardiovascular Disease. Circulation. 2004;109(18):2175–80. DOI: 10.1161/01.CIR.0000127957.43874.BB

19. Polonskaya Ya.V., Kashtanova E.V., Murashov I.S., Volkov A.M., Kurguzov A.V., Chernjavskii A.M. et al. Associations of osteocalcin, osteoprotegerin, and calcitonin with inflammation biomarkers in atherosclerotic plaques of coronary arteries. Bulletin of Experimental Biology and Medicine. 2016;162(12):691–4. In Russian

20. Chatrou MLL, Cleutjens JP, van der Vusse GJ, Roijers RB, Mutsaers PHA, Schurgers LJ. Intra-Section Analysis of Human Coronary Arteries Reveals a Potential Role for Micro-Calcifications in Macrophage Recruitment in the Early Stage of Atherosclerosis. PLOS ONE. 2015;10(11):e0142335. DOI: 10.1371/journal.pone.0142335

21. Krzanowski M, Krzanowska K, Dumnicka P, Gajda M, Woziwodzka K, Fedak D et al. Elevated Circulating Osteoprotegerin Levels in the Plasma of Hemodialyzed Patients With Severe Artery Calcification: Elevated OPG Levels in HD Patients With Artery Calcification. Therapeutic Apheresis and Dialysis. 2018;22(5):519–29. DOI: 10.1111/1744-9987.12681